Lonza | L'Utile Operativo



Operating Profit Cambiamento Data
Akzo Nobel EUR 133M 133M 2024-12
Alcon AG USD 395M 63M 2024-12
Almirall EUR 53.03M 68.53M 2024-06
AstraZeneca USD 2.04B 731M 2024-12
BASF EUR 250M 224M 2024-09
Bayer EUR 3.53B 7.35B 2024-12
Beiersdorf EUR 446M 402M 2024-12
Covestro EUR 76M 5M 2024-09
Demant DKK 2.34B 1.32B 2024-12
Fresenius EUR 469M 23M 2024-12
Fresenius Medical Care EUR 258.9M 204.1M 2024-12
Geberit CHF 199.2M 5.5M 2024-09
Genmab DKK 2.19B 89M 2024-12
Givaudan CHF 364.5M 165.5M 2024-06
GlaxoSmithKline GBP 696M 507M 2024-12
GN Store Nord DKK 701M 242M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Johnson Matthey GBP 575M 462M 2024-09
Merck EUR 1.2B 100M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Philips EUR 199M 139M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 4.09B 1.81B 2024-09
Sika AG CHF 417.05M 471.65M 2024-06
Smith & Nephew USD 329M 1000K 2024-12
Solvay EUR 61M 5M 2024-12
UCB EUR 163M 39M 2024-06



Lonza L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.